1-3 of 3
Hua Xie
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma In Vitro and Patient-Derived Xenografts In Vivo

Free
Mengqiu Song, Xuejiao Liu, Kangdong Liu, Ran Zhao, Hai Huang, Yuanyuan Shi, Man Zhang, Silei Zhou, Hua Xie, Hanyong Chen, Yin Li, Yan Zheng, Qiong Wu, Fangfang Liu, Enmin Li, Ann M. Bode, Zigang Dong, Mee-Hyun Lee
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (7): 1540–1553.
https://doi.org/10.1158/1535-7163.MCT-17-0823
Published: 01 July 2018
View articletitled, Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma In Vitro and Patient-Derived Xenografts In Vivo
Open the PDF for Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma In Vitro and Patient-Derived Xenografts In Vivo in another window
Includes: Supplementary data
Journal Articles

Discovery of the Novel mTOR Inhibitor and Its Antitumor Activities In Vitro and In Vivo

Free
Hua Xie, Mee-Hyun Lee, Feng Zhu, Kanamata Reddy, Zunnan Huang, Dong Joon Kim, Yan Li, Cong Peng, Do Young Lim, Soouk Kang, Sung Keun Jung, Xiang Li, Haitao Li, Weiya Ma, Ronald A. Lubet, Jian Ding, Ann M. Bode, Zigang Dong
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (6): 950–958.
https://doi.org/10.1158/1535-7163.MCT-12-1241
Published: 09 June 2013
View articletitled, Discovery of the Novel mTOR Inhibitor and Its Antitumor Activities In Vitro and In Vivo
Open the PDF for Discovery of the Novel mTOR Inhibitor and Its Antitumor Activities In Vitro and In Vivo in another window
Journal Articles

Abstract C50: AST‐6, a novel irreversible inhibitor of the epidermal growth factor receptor 1 and 2, inhibits tumor growth both in vitro and in vivo

Free
Hua Xie, Lipin Lin, Linjiang Tong, Yong Jiang, Yi Wang, Xiaowei Zhang, Meiyu Geng, Jianhui Guo, Jian Ding
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): C50.
https://doi.org/10.1158/1535-7163.TARG-09-C50
Published: 10 December 2009
View articletitled, Abstract C50: AST‐6, a novel irreversible inhibitor of the epidermal growth factor receptor 1 and 2, inhibits tumor growth both in vitro and in vivo